PSC
GMED icon

Piper Sandler & Co’s Globus Medical GMED Stock Holding History

Piper Sandler & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,000
Closed -$492K – 146
2014
Q3 		$492K Buy
+25,000
New +$514K 0.25% 37

Other funds holding GMED

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Piper Sandler & Co's GMED Position: Q4 2014 in Review

Piper Sandler & Co sold out of Globus Medical (GMED) in Q4 2014, closing a stake of 25,000 shares — an estimated $492K sold.

Piper Sandler & Co first reported a position in GMED in Q3 2014 and held it in 1 quarter. The position peaked at $492K in Q3 2014. 184 funds tracked by Wall St. Rank hold GMED as of Q4 2014.

  • Piper Sandler & Co reported no remaining Globus Medical position as of Q4 2014 after selling out during the quarter.
  • Piper Sandler & Co sold 25,000 Globus Medical shares in Q4 2014, an estimated $492K.
  • Piper Sandler & Co first reported a position in Globus Medical in Q3 2014 and held it in 1 quarter.
  • Piper Sandler & Co's Globus Medical position peaked at $492K in Q3 2014.
  • 184 funds tracked by Wall St. Rank held Globus Medical as of Q4 2014.

Based on Piper Sandler & Co's 13F filing for Q4 2014, filed 17 Feb 2015.